VX-264

Vertex's next off-the-shelf diabetes cell therapy follows in predecessor's footsteps to the clinic
Fierce Biotech
Thu, 03/9/23 - 11:24 am
Vertex Pharmaceuticals
type 1 diabetes
cell therapy
VX-264